Nisa Investment Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

$15.7 Billion
Q2 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 756 shares of LGND stock, worth $73,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares

756

Previous 741 2.02%

Holding current value

$73,611

Previous $54,000 16.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$68.53 - $87.91 $1,027 - $1,318	15 Added 2.02%	756 $63,000
Q1 2024 May 01, 2024	BUY	$68.64 - $89.2 $1,029 - $1,338	15 Added 2.07%	741 $54,000
Q4 2023 Jan 25, 2024	BUY	$49.57 - $72.63 $495 - $726	10 Added 1.4%	726 $51,000
Q3 2023 Nov 02, 2023	SELL	$58.86 - $72.67 $470 - $581	-8 Reduced 1.1%	716 $42,000
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $4,171 - $4,759	60 Added 9.04%	724 $52,000
Q3 2022 Nov 07, 2022	BUY	$0.01 - $107.56 $0 - $1,290	12 Added 1.84%	664 $58,000
Q2 2022 Aug 03, 2022	SELL	$74.52 - $117.06 $7,452 - $11,706	-100 Reduced 13.3%	652 $58,000
Q1 2022 Apr 29, 2022	BUY	$94.99 - $151.56 $3,514 - $5,607	37 Added 5.17%	752 $85,000
Q1 2021 Apr 26, 2021	BUY	$99.52 - $215.83 $19,904 - $43,166	200 Added 38.83%	715 $109,000
Q4 2020 Jan 25, 2021	SELL	$80.55 - $106.05 $48,330 - $63,630	-600 Reduced 53.81%	515 $51,000
Q3 2020 Oct 20, 2020	BUY	$89.56 - $126.72 $48,362 - $68,428	540 Added 93.91%	1,115 $106,000
Q2 2020 Jul 27, 2020	SELL	$68.28 - $123.65 $65,207 - $118,085	-955 Reduced 62.42%	575 $64,000
Q1 2020 Apr 17, 2020	BUY	$63.37 - $107.88 $17,109 - $29,127	270 Added 21.43%	1,530 $111,000
Q4 2019 Jan 17, 2020	BUY	$96.94 - $113.59 $19,388 - $22,718	200 Added 18.87%	1,260 $131,000
Q3 2019 Oct 17, 2019	BUY	$86.25 - $120.16 $82,800 - $115,353	960 Added 960.0%	1,060 $106,000
Q4 2018 Jan 17, 2019	SELL	$128.36 - $272.13 $993,891 - $2.11 Million	-7,743 Reduced 98.72%	100 $14,000
Q3 2018 Oct 16, 2018	BUY	$211.18 - $274.49 $1.62 Million - $2.11 Million	7,693 Added 5128.67%	7,843 $2.15 Million
Q2 2018 Jul 19, 2018	BUY	$150.77 - $207.98 $7,538 - $10,399	50 Added 50.0%	150 $31,000
Q1 2018 Apr 10, 2018	SELL	$138.63 - $182.62 $6,931 - $9,131	-50 Reduced 33.33%	100 $17,000
Q3 2017 Oct 13, 2017	BUY	$120.91 - $137.94 $18,136 - $20,691	150	150 $20,000

Others Institutions Holding LGND

# of Institutions

247

Shares Held

17.5M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.64B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Ligand Pharmaceuticals Inc Transaction History